LVTX logo

LAVA Therapeutics N.V. (LVTX)

Profile

Full Name

LAVA Therapeutics N.V.

Ticker

NASDAQ: LVTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

IPO

March 26, 2021

Indexes

Not included

Website

https://www.lavatherapeutics.com

Employees

34

Key Details

Price

$1.52(-1.30%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.98M(+77.01% YoY)

Annual EPS

-$0.94(+40.13% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.52
    LVTX price is $1.52

    30-Day Relative Volume

    1.57
    LVTX 30-day relative volume is 1.57

    Price Performance

    Price Most recent change

    -1.3%
    LVTX price was down -1.3% on Aug 15, 2025

    Price YTD change

    +59.83%
    LVTX price is up +59.83% since January 1st

    Price 1-year change

    -16.48%
    LVTX price is down -16.48% year-on-year

    Price 3-year change

    -39.44%
    LVTX price is down -39.44% over the past 3 years

    Price Range

    Price All-time high

    $17.20
    LVTX price is currently -91.16% below its historical high of $17.20

    Price 3-year low

    $0.85
    LVTX price is currently +78.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $39.98M
    LVTX market capitalization is $39.98 million

    Market cap 3-year change

    -38.25%
    LVTX market capitalization is down -38.25% over the past 3 years

    Market cap All-time high

    $401.83M
    LVTX market capitalization is currently -90.05% below its historical high of $401.83 million

    Market cap sector rank

    30.6%
    LVTX market capitalization is higher than 30.6% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.03%
    LVTX shares outstanding is up +0.03% year-on-year

    Shares Outstanding 3-Year Change

    +1.97%
    LVTX shares outstanding is up +1.97% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.24
    LVTX beta is 0.24

    200-day SMA

    $1.31
    LVTX price is currently +16.39% above its 200-day simple moving average

    50-day SMA

    $1.40
    LVTX price is currently +8.49% above its 50-day simple moving average

    RSI

    56.98
    LVTX 14-day relative strength index is 56.98

    Volume

    1.57
    LVTX 30-day relative volume is 1.57

    ATR

    $0.08
    LVTX average true range is $0.08

    10-day Historical Volatility

    23.06%
    LVTX 10-day historical volatility is 23.06%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $11.98M
    LVTX annual revenue is $11.98 million

    Revenue Analysts estimate

    -
    LVTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +77.01%
    LVTX annual revenue is up +77.01% year-on-year

    Revenue Sector rank

    50.08%
    LVTX annual revenue is higher than 50.08% of companies in Healthcare sector

    EPS

    EPS

    -$0.94
    LVTX annual earnings per share is -$0.94

    EPS Analysts estimate

    -$0.77
    LVTX annual earnings per share is currently +21.53% higher than the consensus analysts' forecast

    EPS 1-year change

    +40.13%
    LVTX annual earnings per share is up +40.13% year-on-year

    EPS Sector rank

    53.53%
    LVTX annual earnings per share is higher than 53.53% of companies in Healthcare sector

    Profit

    Gross profit

    $11.98M
    LVTX annual gross profit is $11.98 million

    Gross margin

    96.10%
    LVTX annual gross profit margin is 96.10%

    Operating profit

    -$29.69M
    LVTX annual operating income is -$29.69 million

    Operating margin

    -247.79%
    LVTX annual operating profit margin is -247.79%

    Net income

    -$25.11M
    LVTX annual net profit is -$25.11 million

    Net margin

    -209.60%
    LVTX annual net profit margin is -209.60%

    Expenses

    Total expenses

    $41.67M
    LVTX annual total expenses is $41.67 million

    Operating expenses

    $41.67M
    LVTX annual total operating expenses is $41.67 million

    Cost of goods sold

    $467.00K
    LVTX annual cost of goods sold is $467.00 thousand

    Selling, general & administrative expenses

    $13.22M
    LVTX annual SGA is $13.22 million

    Depreciation and amortization

    $467.00K
    LVTX annual depreciation & amortization is $467.00 thousand

    Interest expense

    $515.00K
    LVTX annual interest expense is $515.00 thousand

    Income tax

    $630.00K
    LVTX annual income tax is $630.00 thousand

    EBIT & EBITDA

    EBIT

    -$23.97M
    LVTX annual earnings before interest & taxes is -$23.97 million

    EBITDA

    -$23.50M
    LVTX annual EBITDA is -$23.50 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $80.83M
    LVTX annual total assets is $80.83 million

    Non current assets

    $1.53M
    LVTX annual long term assets is $1.53 million

    Current assets

    $79.30M
    LVTX annual total current assets is $79.30 million

    Cash and cash equivalents

    $35.02M
    LVTX annual cash & cash equivalents is $35.02 million

    Accounts receivable

    -
    LVTX annual accounts receivable value is unknown

    Inventory

    $0.00
    LVTX annual inventory is $0.00

    Liabilities

    Total liabilities

    $53.09M
    LVTX annual total liabilities is $53.09 million

    Long term liabilities

    $35.08M
    LVTX annual total long term liabilities is $35.08 million

    Current liabilities

    $18.01M
    LVTX annual total current liabilities is $18.01 million

    Accounts payable

    $2.72M
    LVTX annual accounts payable is $2.72 million

    Debt

    Total debt

    $5.28M
    LVTX annual total debt is $5.28 million

    Total debt 1-year change

    -13.6%
    LVTX annual total debt is down -13.6% year-on-year

    Long term debt

    $80.00K
    LVTX annual long term debt is $80.00 thousand

    Short term debt

    $5.20M
    LVTX annual short term debt is $5.20 million

    Equity & Capital

    Shareholders equity

    $27.75M
    LVTX annual stockholders equity is $27.75 million

    Book value

    $27.75M
    LVTX annual book value is $27.75 million

    Retained earnings

    -$174.97M
    LVTX annual retained earnings is -$174.97 million

    Working capital

    $61.29M
    LVTX annual working capital is $61.29 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$19.54M
    LVTX annual cash flow from operations is -$19.54 million

    Cash from operations 1-year change

    +51.48%
    LVTX annual cash flow from operations is up +51.48% year-on-year

    Cash from investing

    $12.47M
    LVTX annual cash flow from investing activities is $12.47 million

    Cash from investing 1-year change

    +170.74%
    LVTX annual cash flow from investing activities is up +170.74% year-on-year

    Cash from financing

    -$569.00K
    LVTX annual cash flow from financing activities is -$569.00 thousand

    Cash from financing 1-year change

    -100%
    LVTX annual cash flow from financing activities is down -100% year-on-year

    CAPEX

    CAPEX

    $23.00K
    LVTX annual capital expenditures is $23.00 thousand

    CAPEX 1-year change

    -96.85%
    LVTX annual capital expenditures is down -96.85% year-on-year

    Free Cash Flow

    Free cash flow

    -$19.57M
    LVTX annual free cash flow is -$19.57 million

    Free cash flow 1-year change

    +52.29%
    LVTX annual free cash flow is up +52.29% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    96.10%
    LVTX annual gross profit margin is 96.10%

    Operating margin

    -247.79%
    LVTX annual operating profit margin is -247.79%

    Net margin

    -209.60%
    LVTX annual net profit margin is -209.60%

    ROA & ROE

    ROA

    -27.52%
    LVTX annual return on assets is -27.52%

    ROE

    -63.49%
    LVTX annual return on equity is -63.49%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LVTX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LVTX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.01
    LVTX price to book ratio is 2.01

    PB ratio Sector rank

    55.26%
    LVTX price to book ratio is higher than 55.26% of companies in Healthcare sector

    PS Ratio

    PS ratio

    8.01
    LVTX price to sales ratio is 8.01

    PS ratio Sector rank

    70.05%
    LVTX price to sales ratio is higher than 70.05% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -
    LVTX enterprise value value is unknown

    Enterprise value Sector rank

    -
    LVTX enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    LVTX EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    LVTX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.40
    LVTX annual current ratio is 4.40

    Quick ratio

    4.40
    LVTX annual quick ratio is 4.40

    Leverage

    Debt to equity

    0.19
    LVTX annual debt to equity ratio is 0.19

    Interest coverage ratio

    -46.54
    LVTX annual interest coverage ratio is -46.54

    Risk & Stability

    Piotroski F-Score

    -
    LVTX piotroski f-score value is unknown

    Altman Z-Score

    -2.50
    LVTX altman z-score is -2.50

    Analyst ratings

    Recent major analysts updates

    Aug 5, 25 Jefferies
    Hold
    Aug 5, 25 HC Wainwright & Co.
    Neutral
    May 15, 25 JMP Securities
    Market Perform
    Mar 31, 25 HC Wainwright & Co.
    Neutral
    Feb 27, 25 HC Wainwright & Co.
    Neutral
    Dec 20, 24 HC Wainwright & Co.
    Buy
    Dec 12, 24 Leerink Partners
    Market Perform
    Dec 11, 24 JMP Securities
    Market Perform
    Aug 21, 24 JMP Securities
    Market Outperform
    Jun 28, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with LVTX included

    Growing Shares Outstanding
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    Stocks above analysts price target
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for LAVA Therapeutics N.V.?
    • Does LAVA Therapeutics N.V. pay dividends?
    • What sector is LAVA Therapeutics N.V. in?
    • What industry is LAVA Therapeutics N.V. in?
    • What country is LAVA Therapeutics N.V. based in?
    • When did LAVA Therapeutics N.V. go public?
    • Is LAVA Therapeutics N.V. in the S&P 500?
    • Is LAVA Therapeutics N.V. in the NASDAQ 100?
    • Is LAVA Therapeutics N.V. in the Dow Jones?
    • When was LAVA Therapeutics N.V.'s last earnings report?
    • When does LAVA Therapeutics N.V. report earnings?

    What is the ticker symbol for LAVA Therapeutics N.V.?

    The ticker symbol for LAVA Therapeutics N.V. is NASDAQ:LVTX

    Does LAVA Therapeutics N.V. pay dividends?

    No, LAVA Therapeutics N.V. does not pay dividends

    What sector is LAVA Therapeutics N.V. in?

    LAVA Therapeutics N.V. is in the Healthcare sector

    What industry is LAVA Therapeutics N.V. in?

    LAVA Therapeutics N.V. is in the Biotechnology industry

    What country is LAVA Therapeutics N.V. based in?

    LAVA Therapeutics N.V. is headquartered in Netherlands

    When did LAVA Therapeutics N.V. go public?

    LAVA Therapeutics N.V.'s initial public offering (IPO) was on March 26, 2021

    Is LAVA Therapeutics N.V. in the S&P 500?

    No, LAVA Therapeutics N.V. is not included in the S&P 500 index

    Is LAVA Therapeutics N.V. in the NASDAQ 100?

    No, LAVA Therapeutics N.V. is not included in the NASDAQ 100 index

    Is LAVA Therapeutics N.V. in the Dow Jones?

    No, LAVA Therapeutics N.V. is not included in the Dow Jones index

    When was LAVA Therapeutics N.V.'s last earnings report?

    LAVA Therapeutics N.V.'s most recent earnings report was on May 20, 2025

    When does LAVA Therapeutics N.V. report earnings?

    The date for LAVA Therapeutics N.V.'s next earnings report has not been announced yet
    On this page